Patient Collaborations

Having access to appropriate pain treatment is a basic human right.¹
Grünenthal is committed to embedding patient engagement through each stage in the lifecycle of our medicines and beyond. We believe that we will achieve this most effectively by working in close partnership with people living with pain, their representatives and carers, and patient organisations in the following areas:
 

How do we work in partnership with patients and patient representatives?

Grünenthal co-operates with patients to support research, healthcare, and education respecting the following principles:

1. Develop and sustain mutually beneficial relationships with the patient community
2. Ensure there is clarity around the roles of all parties involved
3. Collaborate with patients as equal partners
4. Value and respect the knowledge, skills, and independence of the patient representatives
5. Nurture a culture of mutual respect based on transpa rency and high quality, and with regular communication
6. Develop a long-term commitment to collaborate on topics of high importance to patients
7. Use a co-creation approach to ensure patient-centricity of the clinical development programme, including priority setting and impact measures during the evaluation.
8. Encourage constructive challenge in a quest for new ideas, learning, and continuous improvement
9. Interact in a transparent and ethical manner and publish transfer of values to patient organisations.